期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 13 Weeks

EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.

The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.

EJNMMI Research 發(fā)表核醫(yī)學(xué)和分子成像領(lǐng)域的新基礎(chǔ)、轉(zhuǎn)化和臨床研究。常規(guī)專題包括原創(chuàng)研究文章、創(chuàng)新研究初步數(shù)據(jù)的快速交流、有趣的病例報(bào)告、社論和致編輯的信。也歡迎有關(guān)基礎(chǔ)科學(xué)、與臨床前和臨床研究或研究倫理方面相關(guān)的基本方面和爭(zhēng)議的教育性文章。及時(shí)的評(píng)論提供有關(guān)當(dāng)前應(yīng)用、成像研究問(wèn)題以及核醫(yī)學(xué)和分子成像技術(shù)的轉(zhuǎn)化方面的最新信息。

主要重點(diǎn)是在分子探針的更廣泛背景下使用放射性藥物進(jìn)行靶向成像的開(kāi)發(fā)，以增強(qiáng)對(duì)疾病背后復(fù)雜生物過(guò)程的理解和表征，并開(kāi)發(fā)、測(cè)試和指導(dǎo)新的治療方式，包括放射性核素治療。

《Ejnmmi Research》(恩米研究)編輯部通訊方式為ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United States, NY, 10004。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。